H-AQLANDVVL^-OH

Ref. 3D-PP49078

Información del producto

• Nombre: H-AQLANDVVL^-OH

Descripción

Peptide H-AQLANDVVL^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AQLANDVVL^-OH include the following: Targeting neuropilin-1 with nanobodies reduces colorectal carcinoma development Y De Vlaeminck , S Bonelli, RM Awad, M Dewilde - Cancers, 2020 - mdpi.comhttps://www.mdpi.com/2072-6694/12/12/3582 VACCINE-INDUCED CD8 T CELL EXPANSION IS PAUSED BY TOPOTECAN YET STILL RESULTS IN SUPERIOR T CELL-MEDIATED TUMOR ERADICATION TC van der Sluis , S van Duikeren, CJM Melief - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A3204213/download Amplificacion de la respuesta antitumoral mediada por linfocitos T CD8+ de memoria residente JP Saavedra Almarza - 2019 - repositorio.uchile.clhttps://repositorio.uchile.cl/handle/2250/174671 A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists JJ Baljon , AJ Kwiatkowski , HM Pagendarm , PT Stone - ACS , 2024 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsnano.3c04471 Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells F Baharom , RA Ramirez-Valdez, KKS Tobin - Nature , 2021 - nature.comhttps://www.nature.com/articles/s41590-020-00810-3 Co-Delivery of Peptide Neoantigens and Stimulator of Interferon Genes (STING) Agonists Enhances Response to Cancer Vaccines D Shae , JJ Baljon , M Wehbe , PP Christov, KW Becker - academia.eduhttps://www.academia.edu/download/89775167/pdf.pdf Co-delivery of peptide neoantigens and stimulator of interferon genes agonists enhances response to cancer vaccines D Shae , JJ Baljon , M Wehbe , PP Christov, KW Becker - ACS , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsnano.0c02765

• Marca: Biosynth